Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-09-04 | New | $200,099,964 | Unknown | Equity Only | SEC link | |
| 2024-10-17 | New | $421,779,808 | $421,779,808 | Equity Only | 06b | SEC link |
| 2022-10-11 | New | $261,266,523 | $261,266,523 | Equity Only | 06b | SEC link |
| 2021-04-30 | New | $211,669,568 | Unknown | Equity Only | SEC link |
| Name | Role |
|---|---|
| Joshua H. Bilenker | Director, Executive, Promoter |
| David Bonita | Director |
| Kristina Burow | Director |
| Steven Elms | Director |
| Jeffrey Engelman | Director, Executive, Promoter |
| Aftab Kherani | Director |
| Avi Naider | Director |
| Ali Satvat | Director |
| David Schenkein | Director |